Circulating thyrotropin receptor messenger ribonucleic acid is not an effective marker in the follow-up of differentiated thyroid carcinoma

BACKGROUND: Circulating thyrotropin receptor messenger ribonucleic acid (TSHR mRNA) assay has been validated in the follow-up of differentiated thyroid carcinoma (DTC) because of its high sensitivity during thyroid hormone therapy and no interference with endogenous anti-thyroglobulin antibodies (Tg...

全面介紹

Na minha lista:
書目詳細資料
發表在:Thyroid Res
Main Authors: Ausavarat, Surasawadee, Sriprapaporn, Jiraporn, Satayaban, Busara, Thongnoppakhun, Wanna, Laipiriyakun, Aunchalee, Amornkitticharoen, Boontham, Chanachai, Rujaporn, Pattanachak, Chaveevan
格式: Artigo
語言:Inglês
出版: BioMed Central 2015
主題:
Short Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4523908/
https://ncbi.nlm.nih.gov/pubmed/26244057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-015-0024-4
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍